We are live on ! Find out more
FLAM

First Light Asset Management Portfolio holdings

AUM $1.12B
1-Year Est. Return 114.45%
This Fund
S&P 500
This Quarter Est. Return
+24.29%
1 Year Est. Return
+114.45%
3 Year Est. Return
+266.49%
5 Year Est. Return
+454.92%
10 Year Est. Return
+8,470.94%
AUM
$782M
AUM Growth
+$121M
Cap. Flow
+$72.8K
Cap. Flow %
0.01%
Top 10 Hldgs %
54.41%
Holding
77
New
6
Increased
14
Reduced
30
Closed
8

Top Buys

Rank Stock Value
1
KRMD icon
KORU Medical Systems
KRMD
+$35.2M
2
TNDM icon
Tandem Diabetes Care
TNDM
+$8.16M
3
PTLA
Portola Pharmaceuticals, Inc.
PTLA
+$6.75M
4
VTRS icon
Viatris
VTRS
+$6.41M
5
TEVA icon
Teva Pharmaceuticals
TEVA
+$6.13M

Top Sells

Rank Stock Value
1
AGIO icon
Agios Pharmaceuticals
AGIO
+$10.8M
2
AMRN
Amarin Corp
AMRN
+$8.75M
3
BMY icon
Bristol-Myers Squibb
BMY
+$6.04M
4
TAK icon
Takeda Pharmaceutical
TAK
+$4.87M
5
IONS icon
Ionis Pharmaceuticals
IONS
+$4.82M

Sector Composition

Rank Sector Weight
1 Healthcare 72.61%
2 Communication Services 8.79%
3 Industrials 1.3%
4 Energy 0.94%
5 Financials 0.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BMRN icon
26
BioMarin Pharmaceuticals
BMRN
$11.6B
$8.58M 1.1%
101,510
-2,042
-2% -$154K
ARNA
27
DELISTED
Arena Pharmaceuticals Inc
ARNA
$8.44M 1.08%
185,728
-5,110
-3% -$242K
RARE icon
28
Ultragenyx Pharmaceutical
RARE
$2.45B
$7.45M 0.95%
174,437
-5,222
-3% -$215K
LHCG
29
DELISTED
LHC Group LLC
LHCG
$7.33M 0.94%
53,222
-257
-0.5% -$32K
TRUP icon
30
Trupanion
TRUP
$1.07B
$7.2M 0.92%
192,099
-698
-0.4% -$20.5K
TECH icon
31
Bio-Techne
TECH
$11.2B
$6.17M 0.79%
112,412
-492
-0.4% -$25.8K
VRTX icon
32
Vertex Pharmaceuticals
VRTX
$121B
$5.81M 0.74%
26,517
-98
-0.4% -$19.8K
KIDS icon
33
OrthoPediatrics
KIDS
$519M
$5.71M 0.73%
121,514
-502
-0.4% -$19.4K
BLUE
34
DELISTED
bluebird bio
BLUE
$5.67M 0.72%
4,986
+3,547
+246% +$3.86M
CSII
35
DELISTED
Cardiovascular Systems, Inc.
CSII
$5.12M 0.65%
105,438
-418
-0.4% -$19K
EPZM
36
DELISTED
Epizyme, Inc
EPZM
$4.85M 0.62%
197,243
-816
-0.4% -$12.1K
ELGX
37
DELISTED
Endologix Inc
ELGX
$4.56M 0.58%
2,885,081
+40,764
+1% +$114K
LGND icon
38
Ligand Pharmaceuticals
LGND
$5.76B
$4.54M 0.58%
69,703
-9,771
-12% -$653K
QDEL icon
39
QuidelOrtho
QDEL
$1.14B
$4.06M 0.52%
54,143
-226
-0.4% -$14.6K
SLP icon
40
Simulations Plus
SLP
$369M
$3.62M 0.46%
124,618
-394
-0.3% -$13.3K
ALXN
41
DELISTED
Alexion Pharmaceuticals
ALXN
$2.84M 0.36%
26,284
-414
-2% -$44.3K
IBB icon
42
iShares Biotechnology ETF
IBB
$9.34B
$2.56M 0.33%
21,248
– –
PSCH icon
43
Invesco S&P SmallCap Health Care ETF
PSCH
$163M
$2.23M 0.29%
51,855
– –
IHI icon
44
iShares US Medical Devices ETF
IHI
$3.13B
$2M 0.26%
45,480
– –
XLV icon
45
State Street Health Care Select Sector SPDR ETF
XLV
$41.9B
$1.86M 0.24%
18,241
– –
LMAT icon
46
LeMaitre Vascular
LMAT
$2.32B
$1.75M 0.22%
48,642
-350
-0.7% -$12.1K
GBT
47
DELISTED
Global Blood Therapeutics, Inc.
GBT
$1.11M 0.14%
+14,000
New +$830K
TLGT
48
DELISTED
Teligent, Inc
TLGT
$712K 0.09%
167,150
-154,244
-48% -$958K
BMY icon
49
Bristol-Myers Squibb
BMY
$133B
$655K 0.08%
10,200
-105,500
-91% -$6.04M
TMDX icon
50
Transmedics
TMDX
$2.64B
$513K 0.07%
27,000
– –
1
2
3 4

Similar funds

AIM
Advyzon Investment Management Lisle, Illinois $1.12B AUM 22.08% 1-Year Est. Return
MTCM
Mint Tower Capital Management Amsterdam, Netherlands $1.12B AUM 19.06% 1-Year Est. Return
CNC
Canandaigua National Corp Canandaigua, New York $1.12B AUM
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return
RIM
Rockbridge Investment Management Syracuse, New York $1.11B AUM 13.62% 1-Year Est. Return
CT
Caldwell Trust Venice, Florida $1.12B AUM 21.31% 1-Year Est. Return
SL
Salomon & Ludwin Richmond, Virginia $1.12B AUM 14.38% 1-Year Est. Return
HH
Hilltop Holdings Dallas, Texas $1.11B AUM 24.7% 1-Year Est. Return

First Light Asset Management's Q4 2019 Portfolio in Review

As of Q4 2019, First Light Asset Management held 77 positions worth $782M, up 18% from $662M the previous quarter. Its ten largest holdings account for 54% of the portfolio.

First Light Asset Management's Q4 2019 filing shows 6 new, 14 increased, 30 reduced and 8 closed positions. Its largest new stake was KORU Medical Systems: 7,218,014 shares worth $47.1M. The largest sale was Agios Pharmaceuticals, an estimated $10.8M.

By sector, the portfolio is most concentrated in Healthcare at 73% of assets, up from 68% a quarter earlier, followed by Communication Services and Industrials.

  • First Light Asset Management's largest Q4 2019 buy was KORU Medical Systems: 7,218,014 shares worth $47.1M.
  • First Light Asset Management added most to Tandem Diabetes Care in Q4 2019, an estimated $8.16M increase.
  • First Light Asset Management's biggest Q4 2019 reduction was Amarin Corp, cutting an estimated $8.75M.
  • First Light Asset Management fully exited Agios Pharmaceuticals in Q4 2019, selling an estimated $10.8M.
  • First Light Asset Management's ten largest holdings make up 54% of its $782M portfolio in Q4 2019.
  • First Light Asset Management opened 6 new positions and closed 8 in Q4 2019.
  • First Light Asset Management's portfolio value rose 18% quarter-over-quarter to $782M.

Based on First Light Asset Management's 13F filing for Q4 2019, filed 14 Feb 2020.